This Morning's Research Reports on Chemicals Stocks -- ChromaDex, Gevo, Aceto, and Sociedad Quimica y Minera de Chile

NEW YORK, Jan. 2, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on CDXC, GEVO, ACET, and SQM which can be accessed for free by signing up to www.wallstequities.com/registration. The companies that make up the Diversified Chemical group are largely intermediate producers of a broad array of chemicals and industrial gases. Their products are mostly used as raw materials by manufacturing industries. Pre-market today, WallStEquities.com covers four major industry players: ChromaDex Corp. (NASDAQ: CDXC), Gevo Inc. (NASDAQ: GEVO), Aceto Corp. (NASDAQ: ACET), and Sociedad Quimica y Minera de Chile S.A. (NYSE: SQM). All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration

ChromaDex

Last Friday, shares in Irvine, California-based ChromaDex Corp. ended the session 0.34% higher at $5.88. The stock recorded a trading volume of 420,088 shares, which was above its three months average volume of 364,960 shares. The Company's shares have surged 36.74% over the previous three months and 77.64% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.01% and 47.64%, respectively. Furthermore, shares of ChromaDex, which discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies, have a Relative Strength Index (RSI) of 46.97.  

On December 14^th, 2017, ChromaDex announced important cardiac research by Dr. Mathias Mericksay and colleagues at the l'Université Paris-Sud, and Dr. Charles Brenner and colleagues at the University of Iowa, published in the journal "Circulation." This research revealed that in a mouse model of heart failure, a loss of NAD levels is accompanied by activation of the nicotinamide riboside kinase pathway; administration of NIAGEN® in this model stabilizes NAD levels and leads to protective effects on cardiac function that may someday lead to a new therapeutic option for heart failure patients. Get the full research report on CDXC for free by clicking below at: www.wallstequities.com/registration/?symbol=CDXC

Gevo

Englewood, Colorado headquartered Gevo Inc.'s stock finished 1.40% lower at $0.59 with a total trading volume of 547,402 shares. The stock is trading below their 50-day moving average by 6.67%. Shares of the Company, which focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks in the US, have an RSI of 41.88.  

On December 11^th, 2017, Gevo announced that GE Aviation had commenced jet engine combustor component testing with a jet fuel comprised 100% of Gevo's renewable alcohol-to-jet fuel. The testing is being performed as part of the Federal Aviation Authority's (FAA) Continuous Lower Energy, Emissions and Noise Program (CLEEN). CLEEN is the FAA's principal environmental effort to accelerate the development of new aircraft and engine technologies, and to advance sustainable alternative jet fuels, in conjunction with aviation industry leaders, such as GE Aviation. Download our actionable research report on GEVO at: www.wallstequities.com/registration/?symbol=GEVO

Aceto

Shares in Port Washington, New York headquartered Aceto Corp. closed the day flat at $10.33. The stock recorded a trading volume of 248,160 shares. The Company's shares are trading above their 50-day moving average by 0.29%. Moreover, shares of Aceto, which together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals, have an RSI of 47.92.  Register for your free report coverage on ACET at: www.wallstequities.com/registration/?symbol=ACET

Sociedad Quimica y Minera de Chile

Santiago, Chile headquartered Sociedad Quimica y Minera de Chile S.A.'s shares recorded a trading volume of 409,532 shares last Friday. The stock closed 0.52% higher at $59.37. The Company's shares have advanced 13.26% in the past month, 6.67% in the previous three months, and 107.23% since the start of this year. The stock is trading 4.25% and 31.94% above its 50-day and 200-day moving averages, respectively. Additionally, shares of the Company, which produces and sells specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other products and services, have an RSI of 59.54. Get the free research report on SQM at: www.wallstequities.com/registration/?symbol=SQM

--

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Wall St. Equities